Production (Stage)
InterCure Ltd.
INCR
$1.52
$0.021.33%
NASDAQ
| 12/31/2024 | 09/30/2024 | 12/31/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 97.05M | 118.03M | 118.45M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 97.05M | 118.03M | 118.45M |
| Cost of Revenue | -- | -- | 67.27M | 72.68M | 68.80M |
| Gross Profit | -- | -- | 29.79M | 45.35M | 49.65M |
| SG&A Expenses | -- | -- | 26.80M | 31.36M | 31.62M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | 2.69M | 9.61M | 9.84M |
| Total Operating Expenses | -- | -- | 96.86M | 113.81M | 110.45M |
| Operating Income | -- | -- | 190.00K | 4.22M | 8.00M |
| Income Before Tax | -- | -- | -16.20M | 1.63M | 7.87M |
| Income Tax Expenses | -- | -- | 595.30K | -3.37M | -746.70K |
| Earnings from Continuing Operations | -- | -- | -16.79 | 5.00 | 8.61 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | 429.80K | 983.80K | 714.90K |
| Net Income | -- | -- | -16.36M | 5.99M | 9.33M |
| EBIT | -- | -- | 190.00K | 4.22M | 8.00M |
| EBITDA | -- | -- | 3.28M | 6.83M | 10.42M |
| EPS Basic | -- | -- | -0.37 | 0.13 | 0.21 |
| Normalized Basic EPS | -- | -- | -0.07 | 0.00 | 0.09 |
| EPS Diluted | -- | -- | -0.37 | 0.13 | 0.20 |
| Normalized Diluted EPS | -- | -- | -0.07 | 0.00 | 0.08 |
| Average Basic Shares Outstanding | -- | -- | 182.29M | 183.43M | 178.24M |
| Average Diluted Shares Outstanding | -- | -- | 182.29M | 183.65M | 179.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |